- Home
- TXG
as 07-01-2025 3:43pm EST
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | PLEASANTON |
| Market Cap: | 1.3B | IPO Year: | 2019 |
| Target Price: | $14.96 | AVG Volume (30 days): | 4.7M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.78 - $24.76 | Next Earning Date: | 08-07-2025 |
| Revenue: | $624,662,000 | Revenue Growth: | -0.13% |
| Revenue Growth (this year): | -2.52% | Revenue Growth (next year): | 6.06% |
Stock Insider Trading Activity of 10x Genomics Inc. (TXG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saxonov Serge | TXG | Chief Executive Officer | May 22 '25 | Sell | $8.30 | 9,343 | $77,540.36 | 1,083,625 | |
| Hindson Benjamin J. | TXG | See Remarks | May 22 '25 | Sell | $8.30 | 7,485 | $62,120.26 | 448,374 | |
| Taich Adam | TXG | Chief Financial Officer | May 22 '25 | Sell | $8.30 | 4,044 | $33,562.37 | 331,588 |
Latest 10x Genomics Inc. News
TXG Breaking Stock News: Dive into TXG Ticker-Specific Updates for Smart Investing
StockStory
8 days ago
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)
Insider Monkey
9 days ago
10x Genomics Settles Patent Dispute With Bruker
StockStory
16 days ago
1 Cash-Producing Stock with Exciting Potential and 2 to Ignore
StockStory
20 days ago
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Be Wary Of
StockStory
22 days ago
TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions
Zacks
a month ago
Wall Street Analysts Think 10x Genomics (TXG) Could Surge 43.12%: Read This Before Placing a Bet
StockStory
a month ago
Powell, Mayville Engineering, Graham Corporation, Hyster-Yale Materials Handling, and 10x Genomics Shares Skyrocket, What You Need To Know
Motley Fool
a month ago
Why 10x Genomics Stock Was Sliding This Week
Compare TXG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TXG 10x Genomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.